Chi-Ling Tseng

Title: Chi-Ling Tseng: Innovator in Lipidated Polypeptides

Introduction

Chi-Ling Tseng is a notable inventor based in Zhunan, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of lipidated polypeptides. With a total of 2 patents to his name, Tseng's work is paving the way for advancements in vaccine technology and therapeutic applications.

Latest Patents

Tseng's latest patents include a method of producing lipidated polypeptides. This method involves providing a host cell adapted to express a recombinant lipidated polypeptide and culturing the host cell in a minimal medium under conditions that allow expression of the polypeptide in lipidated form. Another significant invention is related to lipidated polyepitope vaccines, which includes an isolated lipidated polypeptide featuring a lipid moiety at the N-terminus and a plurality of epitopes, along with methods for making and using the polypeptide.

Career Highlights

Chi-Ling Tseng is currently affiliated with the National Health Research Institutes, where he continues to innovate and contribute to health research. His work focuses on enhancing the efficacy of vaccines and therapeutic agents through the use of lipidated polypeptides.

Collaborations

Tseng collaborates with esteemed colleagues, including Chih-Hsiang Leng and Hsin-Wei Chen, to further advance research in his field. Their combined expertise fosters a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Chi-Ling Tseng's innovative work in lipidated polypeptides is making a significant impact in biotechnology and vaccine development. His contributions are essential for the advancement of therapeutic solutions in healthcare.